Philadelphia, PA, United States of America

Boris Sokolov

This inventor holds 1 USPTO granted patent. Top assignee: Thomas Jefferson University. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boris Sokolov. Retrieved from https://idiyas.com/inventor/boris-sokolov-oxop224e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Boris Sokolov

Introduction

Boris Sokolov is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of genetic research, particularly in the development of transgenic models for studying human diseases. His work has implications for understanding and treating various genetic disorders.

Latest Patents

One of Boris Sokolov's key inventions is a patent for "Transgenic mice expressing a mutated human collagen gene." This invention involves transgenic mice that contain a mutated human collagen gene in nearly all of their cells. The patent provides methods for testing therapies aimed at treating conditions such as osteogenesis imperfecta, osteoporosis, and chondrodysplasia. This innovative approach allows for more effective research into potential treatments for these serious conditions.

Career Highlights

Boris Sokolov is affiliated with Thomas Jefferson University, where he conducts his research. His work at the university has positioned him as a leader in the field of genetic engineering and transgenic research. His contributions have been recognized within the scientific community, and he continues to push the boundaries of what is possible in genetic research.

Collaborations

Throughout his career, Boris has collaborated with esteemed colleagues such as Philipp Vandenberg and Heikki Helminen. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Boris Sokolov's innovative work in developing transgenic mice has opened new avenues for research in genetic disorders. His contributions are vital for advancing our understanding of complex diseases and developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…